Rating History for 9/9/2026
| Company (Firm - Analyst) | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details | ||
|---|---|---|---|---|---|---|---|---|---|
| 10X Genomics
(UBS - Douglas Schenkel) |
TXG | New Coverage | Neutral (N/A) |
68.00 (N/A) |
65.60 (88.50) |
34.91% | Details | ||
| Abivax
(Goldman Sachs - Rajan Sharma) |
ABVX | New Coverage | Buy (N/A) |
155.00 (N/A) |
118.95 (96.85) |
-18.58% | Details | ||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
![]() |
|||||||||
| 310 more... | |||||||||


